INTEGRIS Cancer Institute Proton Campus

Oklahoma City, Oklahoma 73142

0 studies enrolling now · 1 studies all time

What they study most

MPN (Myeloproliferative Neoplasms)

Studies at this site

• Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272) — Stopped early